The mural is located in the CEIP Pinedo of Valencia and is a piece by the artist Marta Lapeña. This is the mural number 27 of the project with which the UPV and Las Naves are filling the Valencian educational centers with science and art, in feminine.
New mural in tribute to Dr. Anna Veiga Read More »
It begins the selection of candidates to carry out a doctoral program in Regenerative Medicine between the SZBL and the IDIBELL. The program will run mainly at SZBL and will have a minimum six months stay at IDIBELL.
Begins the exchange program between IDIBELL and SZBL Read More »
SZBL and IDIBELL launch their joint PhD Exchange Program call for 2022, with the aim of fostering collaboration in research between both institutions in the field of Regenerative Medicine and providing exceptional training in the field for graduated students by promoting mobility and allowing interaction with outstanding researchers.
Joint SZBL-IDIBELL PhD Exchange Program (2022 Call) Read More »
Neurofibromas are tumors of the peripheral nervous system, which develop in people with a hereditary disease, and they are the main cause of death among those people.
One of the hallmarks of Parkinson’s disease is the abnormal accumulation of the α-synuclein protein that causes neuronal death responsible for motor impairments. Dendrimers are highly branched polymers that decrease α-synuclein accumulation in dopaminergic neurons derived from patient stem cells.
A research team from IDIBELL, CRG and UB has uncovered the role of a gene that is critical to boosting the number of insulin-producing cells during the early development of the pancreas. The findings could bolster diabetes research efforts and eventually lead to new replacement therapies for the disease.
Pancreatic beta-cell boost in mice paves way for future diabetes treatments Read More »
Researchers from IDIBELL and the University of Barcelona (UB) have described that neurons derived from Parkinson’s patients show impairments in their transmission before neurodegeneration.
Identified an early neuronal dysfunction in Parkinson’s that could help early diagnosis Read More »
Dr. Anna Veiga is leading the project CRISPR/Cas9 human embryo genome editing (GE) for the study of genes related to early embryo development.
To equilibrate the gene expression between XX females and XY males, one of female X chromosomes is inactivated. Researchers from IDIBELL Regenerative Program has discovered that this inactivation is affected in bone marrow aged stem cells.
P-CMR[C] researchers define a new mechanism of aging in a bone marrow stem cell in women Read More »
The research group led by Dr. Alessandra Giorgetti, leader of the research group “Biology of Hematopoietic Stem Cells and Leukemogenesis” of IDIBELL, and professor at the UB, has received a grant of € 15,000 from the GESMD (Spanish Group of Myelodysplastic Syndromes), a group of which Giorgetti is an active member.
